effect of alpha lipoic acid on cardiac autonomic function and platelet reactivity in type I diabetes
In patients with type I diabetes is alpha lipoic acid better than placebo for improvement of cardiac autonomic function and reduction of platelet reactivity?
Catholic University
60 participants
Dec 1, 2009
Interventional
Conditions
Summary
The present randomized study will evaluate the effect of alpha lipoic acid compared to placebo on cardiac autonomic function and platelet reactivity in type I diabetic patients
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
alpha lipoic acid dose: 800 mg once per day duration of administration: 4 weeks mode of administration: oral capsules
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12610000291088